Sherman Oaks, CA, United States of America

Randolph Wall

This inventor holds 7 USPTO granted patents. Top assignee: Xoma Corporation. Active years: 1997-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Randolph Wall. Retrieved from https://idiyas.com/inventor/randolph-wall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 7

Forward Citations = 975(Granted Patents)


Company Filing History:


Years Active: 1997-2001

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Randolph Wall

Introduction

Randolph Wall is a notable inventor based in Sherman Oaks, CA. He has made significant contributions to the field of biotechnology, holding a total of 7 patents. His work primarily focuses on the development of antibody genes and their applications.

Latest Patents

Among his latest patents is the invention titled "Modular assembly of antibody genes, antibodies prepared thereby and use." This patent showcases his innovative approach to antibody development. Another significant patent is related to the "Pectate lyase signal sequence." This invention is directed to the pectate lyase B secretion signal and its use to express operably linked sequences in bacterial hosts.

Career Highlights

Randolph Wall is currently associated with Xoma Corporation, where he continues to push the boundaries of scientific research and innovation. His work has been instrumental in advancing the understanding of antibody production and its applications in various fields.

Collaborations

He has collaborated with notable colleagues such as Randy R Robinson and Alvin Y Liu, contributing to a dynamic research environment that fosters innovation.

Conclusion

Randolph Wall's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in antibody research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…